Q1 2021 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2021-05-06 | ||||||
REV |
Q4 2020 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2021-03-08 | ||||||
REV |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
Ticker | Company | Price | Change | Chg % | Mkt Cap | |
---|---|---|---|---|---|---|
SNDX | Syndax Pharmaceuticals | 23.58 | 1.00 | 4.43% | 1.1B |
You can purchase shares of Syndax Pharmaceuticals (NASDAQ: SNDX) through any online brokerage.
Other companies in Syndax Pharmaceuticals’s space includes: 4D Molecular Therapeutics (NASDAQ:FDMT), Trillium Therapeutics (NASDAQ:TRIL) and Protagonist Therapeutics (NASDAQ:PTGX).
The latest price target for Syndax Pharmaceuticals (NASDAQ: SNDX) was reported by Morgan Stanley on 2020-12-07. The analyst firm set a price target for 25.00 expecting SNDX to rise to within 12 months (a possible 6.02% upside). 10 analyst firms have reported ratings in the last year.
The stock price for Syndax Pharmaceuticals (NASDAQ: SNDX) is $23.58 last updated Fri Mar 05 2021 21:00:02 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Syndax Pharmaceuticals.
There is no upcoming split for Syndax Pharmaceuticals.